Argitalpenak (74) Ikertzaileren baten partaidetza izan duten argitalpenak

2016

  1. A Cost-Effective Mutation Screening Strategy for Inherited Retinal Dystrophies

    Ophthalmic Research, Vol. 56, Núm. 3, pp. 123-131

  2. A proposal for a model to replace carbamazepine or oxcarbazepine by eslicarbazepine acetate in clinical practice

    Revista de Neurologia, Vol. 63, Núm. 5, pp. 219-223

  3. A study using positron emission tomography of a case of vascular dementia due to left thalamic haematoma, an example of the diaschisis phenomenon

    Revista de Neurologia, Vol. 62, Núm. 9, pp. 408-410

  4. ALS: A bucket of genes, environment, metabolism and unknown ingredients

    Progress in Neurobiology, Vol. 142, pp. 104-129

  5. Absence of LRRK2 mutations in a cohort of patients with idiopathic REM sleep behavior disorder

    Neurology, Vol. 86, Núm. 11, pp. 1072-1073

  6. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 33, pp. 58-64

  7. Assessing the role of TUBA4A gene in frontotemporal degeneration

    Neurobiology of Aging, Vol. 38, pp. 215.e13-215.e14

  8. Associated clinical disorders diagnosed by medical specialists in 188 FMR1 premutation carriers found in the last 25 years in the Spanish Basque Country: A retrospective study

    Genes, Vol. 7, Núm. 10

  9. Automatic non-linear analysis of non-invasive writing signals, applied to essential tremor

    Journal of Applied Logic, Vol. 16, pp. 50-59

  10. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 6, pp. 861-881

  11. Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems

    Maturitas, Vol. 84, pp. 25-31

  12. Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys

    Biomaterials, Vol. 110, pp. 11-23

  13. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  14. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle

    Expert Reviews in Molecular Medicine, Vol. 18

  15. Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation

    Neurology, Vol. 87, Núm. 12, pp. 1250-1257

  16. Combination of thrombolysis and statins in acute stroke is safe: Results of the STARS randomized trial (Stroke Treatment With Acute Reperfusion and Simvastatin)

    Stroke, Vol. 47, Núm. 11, pp. 2870-2873

  17. Congenital Spinal Malformation and Stroke: Aneurysmal Dilatations and Bilateral Rotational Vertebral Artery Occlusion

    Journal of Stroke and Cerebrovascular Diseases, Vol. 25, Núm. 3, pp. e23-e24

  18. DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 3, pp. 335-343

  19. Defining secondary progressive multiple sclerosis

    Brain, Vol. 139, Núm. 9, pp. 2395-2405

  20. Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry

    Journal of Neurology, Vol. 263, Núm. 7, pp. 1401-1408